Quote | Science 37 Holdings Inc. (NASDAQ:SNCE)
Last: | $5.75 |
---|---|
Change Percent: | 0.17% |
Open: | $5.74 |
Close: | $5.75 |
High: | $5.75 |
Low: | $5.73 |
Volume: | 49,100 |
Last Trade Date Time: | 03/11/2024 03:00:00 am |
News | Science 37 Holdings Inc. (NASDAQ:SNCE)
RESEARCH TRIANGLE PARK, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. today announced the preliminary outcome of its recent FDA Inspection focusing on critical areas and documentation. The nearly two-week review included, but was not limited to, the Science 37 Metasite&...
Science 37’s Patient Recruitment Recognized in Prestigious International Annual Awards Program for Standout Digital Health & Medical Technology Products and Companies RESEARCH TRIANGLE PARK, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. , today announ...
Message Board Posts | Science 37 Holdings Inc. (NASDAQ:SNCE)
Subject | By | Source | When |
---|---|---|---|
What a nice move | INFINITI | investorshub | 03/17/2023 7:59:13 PM |
i would ave down but not sure what | gail | investorshub | 03/16/2023 7:05:46 PM |
Me and you both lol | INFINITI | investorshub | 03/16/2023 7:04:00 PM |
Just missed this wtf | INFINITI | investorshub | 03/16/2023 7:03:48 PM |
looks like i hopped in too soon, lol | gail | investorshub | 03/16/2023 6:59:05 PM |
News, Short Squeeze, Breakout and More Instantly...
Science 37 Holdings Inc. Company Name:
SNCE Stock Symbol:
NASDAQ Market:
RESEARCH TRIANGLE PARK, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. today announced the preliminary outcome of its recent FDA Inspection focusing on critical areas and documentation. The nearly two-week review included, but was not limited to, the Science 37 Metasite&...
Science 37’s Patient Recruitment Recognized in Prestigious International Annual Awards Program for Standout Digital Health & Medical Technology Products and Companies RESEARCH TRIANGLE PARK, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. , today announ...
RESEARCH TRIANGLE PARK, N.C., May 02, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. today disclosed the latest enrollment figures resulting from its Metasite™ and Patient Recruitment partnership with a leading biotech company whose asthma drug is currently undergoing a Phase 3...